Remarkably suppressed manganese superoxide dismutase activity in malignant pheochromocytoma - PubMed (original) (raw)
. 1995 Jun;153(6):1787-90.
Affiliations
- PMID: 7752317
Remarkably suppressed manganese superoxide dismutase activity in malignant pheochromocytoma
T Nakada et al. J Urol. 1995 Jun.
Abstract
There are almost no special histopathological characteristics or criteria that exactly define a malignant pheochromocytoma. Tissue concentrations of catecholamine metabolites and superoxide dismutase activity have been proposed as possible candidates for discriminating between benign and malignant pheochromocytomas. Tissue concentrations of dihydroxyphenylalanine, metanephrine, normetanephrine, vanillylmandelic acid, and 3-methoxy-4-hydroxyphenylethylglycol were determined in 29 normal adrenal medullas, 13 benign pheochromocytomas and 6 malignant pheochromocytomas, respectively. The copper-zinc superoxide dismutase and manganese superoxide dismutase activities in remnants of these tissues were determined by interruption of nitric formation from hydroxylamines. Catecholamine metabolites and copper-zinc superoxide dismutase activity in benign and malignant pheochromocytomas were identical. Manganese superoxide dismutase activity in malignant pheochromocytoma was the lowest among the groups examined. These data suggest that the assay of catecholamine metabolites in removed specimens is not a reliable method for making a differential diagnosis of benign or malignant pheochromocytoma. However, a low level of manganese superoxide dismutase activity in malignant pheochromocytoma may be a marker for malignancy of this neoplasm.
Similar articles
- Low level of superoxide dismutase activity in pheochromocytoma.
Nakada T, Koike H, Katayama T. Nakada T, et al. J Urol. 1987 Jul;138(1):9-13. doi: 10.1016/s0022-5347(17)42970-3. J Urol. 1987. PMID: 3599227 - Elevated levels of telomerase activity in malignant pheochromocytoma.
Kubota Y, Nakada T, Sasagawa I, Yanai H, Itoh K. Kubota Y, et al. Cancer. 1998 Jan 1;82(1):176-9. Cancer. 1998. PMID: 9428495 - [Malignant pheochromocytoma. A case report and comments on a rare pathology].
Boneschi M, Erba M, Rinaldi P, Cusmai F, Miani S. Boneschi M, et al. Minerva Chir. 1999 Jan-Feb;54(1-2):73-8. Minerva Chir. 1999. PMID: 10230231 Review. Italian. - [Biological diagnosis of pheochromocytoma: impact of technological improvement].
Peyrin L, Mornex R. Peyrin L, et al. Ann Biol Clin (Paris). 1993;51(10-11):835-65. Ann Biol Clin (Paris). 1993. PMID: 8210060 Review. French.
Cited by
- Complex I generated, mitochondrial matrix-directed superoxide is released from the mitochondria through voltage dependent anion channels.
Lustgarten MS, Bhattacharya A, Muller FL, Jang YC, Shimizu T, Shirasawa T, Richardson A, Van Remmen H. Lustgarten MS, et al. Biochem Biophys Res Commun. 2012 Jun 8;422(3):515-21. doi: 10.1016/j.bbrc.2012.05.055. Epub 2012 May 18. Biochem Biophys Res Commun. 2012. PMID: 22613204 Free PMC article. - Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.
Dannenberg H, Komminoth P, Dinjens WN, Speel EJ, de Krijger RR. Dannenberg H, et al. Endocr Pathol. 2003 Winter;14(4):329-50. doi: 10.1385/ep:14:4:329. Endocr Pathol. 2003. PMID: 14739490 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical